First Citizens Bank & Trust Co. Cuts Stock Position in HCA Healthcare, Inc. $HCA

First Citizens Bank & Trust Co. lessened its position in HCA Healthcare, Inc. (NYSE:HCA) by 18.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 8,720 shares of the company’s stock after selling 1,955 shares during the quarter. First Citizens Bank & Trust Co.’s holdings in HCA Healthcare were worth $3,341,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of HCA. Nuveen LLC purchased a new stake in shares of HCA Healthcare in the 1st quarter valued at $569,217,000. Pacer Advisors Inc. grew its stake in HCA Healthcare by 6,237.9% during the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock worth $466,815,000 after purchasing an additional 1,329,618 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in HCA Healthcare by 83.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock worth $829,104,000 after purchasing an additional 1,091,416 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in HCA Healthcare by 49.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock worth $615,583,000 after purchasing an additional 587,036 shares in the last quarter. Finally, Abdiel Capital Advisors LP acquired a new position in HCA Healthcare during the 1st quarter worth $164,835,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Down 0.3%

Shares of NYSE HCA opened at $440.07 on Friday. The stock has a market cap of $102.97 billion, a PE ratio of 18.50, a price-to-earnings-growth ratio of 1.39 and a beta of 1.40. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $447.09. The business has a 50-day moving average price of $413.82 and a 200 day moving average price of $380.88.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analysts’ expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business’s revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm earned $5.50 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Morgan Stanley lowered their target price on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a research note on Monday, July 28th. KeyCorp upped their price objective on HCA Healthcare from $370.00 to $465.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. UBS Group upped their price objective on HCA Healthcare from $438.00 to $495.00 and gave the stock a “buy” rating in a research report on Tuesday, October 14th. Jefferies Financial Group upped their price objective on HCA Healthcare from $400.00 to $485.00 in a research report on Wednesday, October 15th. Finally, Truist Financial set a $460.00 price objective on HCA Healthcare in a research report on Tuesday, October 14th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $437.19.

Insider Activity

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.